Is Metabolic Flexibility Altered in Multiple Sclerosis Patients?

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Mähler, Anja ^a   Steiniger, Jochen ^a   Bock, Markus ^a   Brandt, Alexander U ^a   Haas, Verena ^a   Boschmann, Michael ^a   Paul, Friedemann ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FATTY ACID; GLATIRAMER; GLUCOSE; GLYCEROL; INSULIN; LACTIC ACID;

ADIPOSE TISSUE; ADULT; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; DIET RESTRICTION; ENERGY EXPENDITURE; ENERGY METABOLISM; EXERCISE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; LIPID OXIDATION; MALE; METABOLIC FLEXIBILITY; MICRODIALYSIS; MULTIPLE SCLEROSIS; MUSCLE; ORAL GLUCOSE TOLERANCE TEST; REST; SKELETAL MUSCLE; STEADY STATE; TISSUE LEVEL;

ADULT; CARBOHYDRATE METABOLISM; CASE-CONTROL STUDIES; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; ENERGY METABOLISM; FASTING; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; LIPID METABOLISM; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OXIDATION-REDUCTION;

EID: 84865466843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043675     Document Type: Article

References (43)

1. Compston A, Coles A, (2008) Multiple sclerosis. Lancet 372: 1502-1517.
2. White LJ, Dressendorfer RH, (2004) Exercise and multiple sclerosis. Sports Med 34: 1077-1100.
3. Witte ME, Geurts JJ, de Vries HE, van d, V, van HJ, (2010) Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 10: 411-418.
4. Nikic I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, et al. (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17: 495-499.
5. Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, et al. (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132: 1161-1174.
6. Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, et al. (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69: 481-492.
7. Arenas J, Campos Y, Ribacoba R, Martin MA, Rubio JC, et al. (1998) Complex I defect in muscle from patients with Huntington's disease. Ann Neurol 43: 397-400.
8. Lodi R, Schapira AH, Manners D, Styles P, Wood NW, et al. (2000) Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol 48: 72-76.
9. Aziz NA, Pijl H, Frolich M, Snel M, Streefland TC, et al. (2010) Systemic energy homeostasis in Huntington's disease patients. J Neurol Neurosurg Psychiatry 81: 1233-1237.
10. Regenold WT, Phatak P, Makley MJ, Stone RD, Kling MA, (2008) Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression. J Neurol Sci 275: 106-112.
11. Kumleh HH, Riazi GH, Houshmand M, Sanati MH, Gharagozli K, et al. (2006) Complex I deficiency in Persian multiple sclerosis patients. J Neurol Sci 243: 65-69.
12. Kelley DE, He J, Menshikova EV, Ritov VB, (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950.
13. Argov Z, (1998) Functional evaluation techniques in mitochondrial disorders. Eur Neurol 39: 65-71.
14. Damian MS, Sauter W, Reichmann H, (2001) Subcutaneous microdialysis in mitochondrial cytopathy. Muscle Nerve 24: 648-653.
15. Galgani JE, Moro C, Ravussin E (2008) Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 295: E1009-E1017. 90558.2008 [pii];10.1152/ajpendo.90558.2008 [doi].
16. Boschmann M, Engeli S, Moro C, Luedtke A, Adams F, et al. (2010) LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J Clin Endocrinol Metab 95: 1634-1643.
17. Boschmann M, Engeli S, Adams F, Gorzelniak K, Franke G, et al. (2005) Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives. Hypertension 46: 130-136.
18. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846.
19. Kurtzke JF, (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
20. Fellander G, Linde B, Bolinder J, (1996) Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Relat Metab Disord 20: 220-226.
21. Hickner RC, Ekelund U, Mellander S, Ungerstedt U, Henriksson J, (1995) Muscle blood flow in cats: comparison of microdialysis ethanol technique with direct measurement. J Appl Physiol 79: 638-647.
22. Ferrannini E (1988) The theoretical bases of indirect calorimetry: a review. Metabolism 37: 287-301. 0026-0495(88)90110-2 [pii].
23. Pols MA, Peeters PH, Ocke MC, Slimani N, Bueno-de-Mesquita HB, et al. (1997) Estimation of reproducibility and relative validity of the questions included in the EPIC Physical Activity Questionnaire. Int J Epidemiol 26Suppl 1: S181-S189.
24. Muller MJ, Bosy-Westphal A, Klaus S, Kreymann G, Luhrmann PM, et al. (2004) World Health Organization equations have shortcomings for predicting resting energy expenditure in persons from a modern, affluent population: generation of a new reference standard from a retrospective analysis of a German database of resting energy expenditure. Am J Clin Nutr 80: 1379-1390.
25. Anonymous (2001) Human energy requirements: Report of a Joint FAO/WHO/UNU Expert Consultation.
26. Stahle L, Segersvard S, Ungerstedt U, (1991) A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J Pharmacol Methods 25: 41-52.
27. Brunner E., Domhof S., and Langer F. (2002) Nonparametric Analysis of Longitudinal Data in Factorial Experiments. New York: Wiley.
28. Enoksson S, Nordenstrom J, Bolinder J, Arner P, (1995) Influence of local blood flow on glycerol levels in human adipose tissue. Int J Obes Relat Metab Disord 19: 350-354.
29. Vogt J, Paul F, Aktas O, Muller-Wielsch K, Dorr J, et al. (2009) Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol 66: 310-322.
30. Frayn, F N. (2003) Metabolic Regulation A Human Perspective. Oxford: Blackwell Science.
31. Carroll CC, Gallagher PM, Seidle ME, Trappe SW, (2005) Skeletal muscle characteristics of people with multiple sclerosis. Arch Phys Med Rehabil 86: 224-229.
32. Garner DJ, Widrick JJ, (2003) Cross-bridge mechanisms of muscle weakness in multiple sclerosis. Muscle Nerve 27: 456-464.
33. Kent-Braun JA, Ng AV, Castro M, Weiner MW, Gelinas D, et al. (1997) Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis. J Appl Physiol 83: 1998-2004.
34. Rossi P, Andriesse GI, Oey PL, Wieneke GH, Roelofs JM, et al. (1998) Stomach distension increases efferent muscle sympathetic nerve activity and blood pressure in healthy humans. J Neurol Sci 161: 148-155.
35. Flachenecker P, Reiners K, Krauser M, Wolf A, Toyka KV, (2001) Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler 7: 327-334.
36. Flachenecker P, Rufer A, Bihler I, Hippel C, Reiners K, et al. (2003) Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology 61: 851-853.
37. Haensch CA, Jorg J (2006) Autonomic dysfunction in multiple sclerosis. J Neurol 253 Suppl 1: I3-I9. 10.1007/s00415-006-1102-2 [doi].
38. Randle PJ, Garland PB, Hales CN, Newsholme EA, (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789.
39. Corpeleijn E, Hessvik NP, Bakke SS, Levin K, Blaak EE, et al. (2010) Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids. Am J Physiol Endocrinol Metab 299: E14-E22.
40. Gaster M, (2011) Mitochondrial mass is inversely correlated to complete lipid oxidation in human myotubes. Biochem Biophys Res Commun 404: 1023-1028.
41. Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R, (1997) Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid Use. Calcif Tissue Int 61: 129-133.
42. Shelton RC, Miller AH, (2010) Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 91: 275-299.
43. Mancardi GL, Murialdo A, Drago F, Brusati C, Croce R, et al. (2000) Localized lipoatrophy after prolonged treatment with copolymer 1. J Neurol 247: 220-221.